ACE Inhibitors (e.g., Lisinopril)
Treatment for Dilated Cardiomyopathy
Typical Dosage: Lisinopril 2.5-40mg daily
Effectiveness
80%
Safety Score
70%
Clinical Trials
500
Participants
100K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Lisinopril 2.5-40mg daily
Time to Effect
2-4 weeks
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
25(Treat 25 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10(Treat 10 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$40
Monitoring:$700
Side Effect Mgmt:$100
Total Annual:$840
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$1,292
Cost per Remission
$21,000
ACE Inhibitors (e.g., Lisinopril) Outcomes
for Dilated Cardiomyopathy
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+65%
Remission Rate
+4%
Common Side Effects
Cough
+10%
Hypotension
+7%
Dizziness
+6%
Hyperkalemia
+3%
Angioedema
+0.3%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov